comparemela.com

Entrada Therapeutics, Inc. (NASDAQ:TRDA – Get Free Report) CEO Dipal Doshi sold 1,800 shares of the business’s stock in a transaction on Thursday, May 16th. The stock was sold at an average price of $15.00, for a total transaction of $27,000.00. Following the transaction, the chief executive officer now owns 338,575 shares in the company, […]

Related Keywords

Wellington ,New Zealand General ,New Zealand ,Dipal Doshi ,Securities Exchange Commission ,Vanguard Group Inc ,Acadian Asset Management ,Nasdaq ,Allspring Global Investments Holdings ,Entrada Therapeutics Inc ,Entrada Therapeutics Company Profile ,Wellington Management Group ,Entrada Therapeutics ,Get Free Report ,Exchange Commission ,Management Group ,Global Investments Holdings ,Entrada Therapeutics Daily ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.